Compare fund portfolios
See how two funds' portfolios overlap. Enter two tickers:
PSCH vs PTH
Shared holdings
10
PSCH covered by PTH
28.80%
PTH covered by PSCH
28.80%
Coverage = share of one portfolio's weight reproduced by the other (overlapping positions, min weight). Top 50 positions per side shown; = held by both — hover a shared position to highlight it in both columns.
PSCH (Feb. 28, 2026)
| Security | Weight | |
|---|---|---|
| Invesco Private Prime Fund | 16.22% | |
| Invesco Private Government Fund | 6.07% | |
| KRYSTAL BIOTECH INC | 3.22% | |
| GLAUKOS CORP | 3.13% | |
| PTC THERAPEUTICS INC | 2.48% | |
| PROTAGONIST THERAPEUTICS INC | 2.45% | |
| TELEFLEX INC | 2.44% | |
| ALKERMES PLC | 2.25% | |
| TRANSMEDICS GROUP INC | 2.25% | |
| RADNET INC | 2.20% | |
| BRIGHTSPRING HEALTH SERVICES INC | 2.13% | |
| MERIT MEDICAL SYSTEMS INC | 2.07% | |
| TG THERAPEUTICS INC | 1.85% | |
| INDIVIOR PHARMACEUTICALS INC | 1.85% | |
| LIGAND PHARMACEUTICALS | 1.77% | |
| ICU MEDICAL INC | 1.68% | |
| ADMA BIOLOGICS INC | 1.68% | |
| CORCEPT THERAPEUTICS INC | 1.51% | |
| PRESTIGE CONSUMER HEALTHCARE INC | 1.51% | |
| SUPERNUS PHARMACEUTICALS INC | 1.42% | |
| ACADIA PHARMACEUTICALS INC | 1.39% | |
| INTEGER HOLDINGS CORP | 1.38% | |
| WAYSTAR HOLDING CORP | 1.33% | |
| VERACYTE INC | 1.31% | |
| CONCENTRA GROUP HOLDINGS PARENT INC | 1.29% | |
| PRIVIA HEALTH GROUP INC | 1.24% | |
| CATALYST PHARMACEUTICALS INC | 1.21% | |
| NEOGEN CORP | 1.11% | |
| AMNEAL PHARM INC | 1.06% | |
| LEMAITRE VASCULAR INC | 1.02% | |
| ACADIA HEALTHCARE CO INC | 0.98% | |
| APELLIS PHARMACEUTICALS INC | 0.97% | |
| NATL HEALTHCARE | 0.92% | |
| ORGANON & CO | 0.86% | |
| ADDUS HOMECARE CORP | 0.86% | |
| OMNICELL INC | 0.84% | |
| PERRIGO CO PLC | 0.82% | |
| VERICEL CORP | 0.82% | |
| SAREPTA THERAPEUTICS INC | 0.80% | |
| ARCUS BIOSCIENCES INC | 0.79% | |
| TANDEM DIABETES CARE INC | 0.78% | |
| INSPIRE MEDICAL SYSTEMS INC | 0.77% | |
| PEDIATRIX MEDICAL GROUP INC | 0.76% | |
| SELECT MEDICAL HLDGS CORP | 0.75% | |
| INNOVIVA INC | 0.74% | |
| UFP TECHNOLOGIES INC | 0.74% | |
| CORVEL CORP | 0.73% | |
| ARTIVION INC | 0.73% | |
| QUIDELORTHO CORP | 0.70% | |
| ENOVIS CORP | 0.66% |
PTH (Jan. 31, 2026)
| Security | Weight | |
|---|---|---|
| Invesco Private Prime Fund | 16.67% | |
| Invesco Private Government Fund | 7.65% | |
| PRAXIS PRECISION MEDICINES INC | 4.01% | |
| GUARDANT HEALTH INC | 3.37% | |
| ROIVANT SCIENCES | 3.21% | |
| TERNS PHARMACEUTICALS INC | 3.16% | |
| ARROWHEAD PHARMACEUTICALS INC | 3.16% | |
| NATERA INC | 2.68% | |
| REVOLUTION MEDICINES INC | 2.50% | |
| TENET HEALTHCARE CORP | 2.24% | |
| AXSOME THERAPEUTICS INC | 2.19% | |
| HCA HEALTHCARE INC | 2.15% | |
| CELCUITY INC | 2.14% | |
| MEDPACE HOLDINGS INC | 2.12% | |
| UNITED THERAPEUTICS CORP DEL | 1.93% | |
| BRIDGEBIO PHARMA INC | 1.90% | |
| MADRIGAL PHARMACEUTICALS INC | 1.77% | |
| COGENT BIOSCIENCES INC | 1.72% | |
| TRAVERE THERAPEUTICS INC | 1.55% | |
| PROTAGONIST THERAPEUTICS INC | 1.44% | |
| ENSIGN GROUP INC | 1.42% | |
| BRIGHTSPRING HEALTH SERVICES INC | 1.42% | |
| STOKE THERAPEUTICS INC | 1.39% | |
| ALIGNMENT HEALTHCARE INC | 1.33% | |
| HARROW INC | 1.25% | |
| PACS GROUP INC | 1.21% | |
| IMMUNOME INC | 1.16% | |
| MIRUM PHARMACEUTICALS INC | 1.13% | |
| TAYSHA GENE THERAPIES INC | 1.03% | |
| ARCUTIS BIOTHERAPEUTICS INC | 1.01% | |
| PTC THERAPEUTICS INC | 1.00% | |
| RAPT THERAPEUTICS INC | 1.00% | |
| LIGAND PHARMACEUTICALS | 0.90% | |
| NUVATION BIO INC | 0.88% | |
| IDEAYA BIOSCIENCES | 0.87% | |
| ALPHATEC HOLDINGS INC | 0.86% | |
| TARSUS PHARMACEUTICALS INC | 0.86% | |
| KYMERA THERAPEUTICS INC | 0.84% | |
| AMNEAL PHARM INC | 0.81% | |
| AXOGEN INC | 0.79% | |
| PRECIGEN INC | 0.71% | |
| KODIAK SCIENCES INC | 0.70% | |
| MONTE ROSA THERAPEUTICS INC | 0.66% | |
| PALVELLA THERAPEUTICS INC | 0.63% | |
| SIONNA THERAPEUTICS INC | 0.63% | |
| MAZE THERAPEUTICS INC | 0.63% | |
| REPLIMUNE GROUP INC | 0.62% | |
| TREVI THERAPEUTICS INC | 0.62% | |
| UPSTREAM BIO INC | 0.60% | |
| ORUKA THERAPEUTICS INC | 0.60% |
Machine-readable: JSON · Markdown. Programmatic access via the agent surface.